|
PL2187965T3
(pl)
|
2007-08-17 |
2020-05-18 |
Purdue Research Foundation |
Koniugaty wiążący psma ligand-łącznik i sposoby ich zastosowania
|
|
US9422234B2
(en)
*
|
2007-11-30 |
2016-08-23 |
The Johns Hopkins University |
Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
|
|
WO2009084995A1
(en)
|
2007-12-28 |
2009-07-09 |
Exini Diagnostics Ab |
System for detecting bone cancer metastases
|
|
PT2318366T
(pt)
*
|
2008-08-01 |
2017-08-02 |
Univ Johns Hopkins |
Agentes de ligação a psma e suas utilizações
|
|
EP2433322A4
(en)
|
2009-05-19 |
2015-11-04 |
East Penn Mfg Co |
COMPOSITE CURRENT COLLECTOR AND RELATED METHODS
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
WO2013028664A1
(en)
|
2011-08-22 |
2013-02-28 |
Siemens Medical Solutions Usa, Inc. |
Psma imaging agents
|
|
US20130116404A1
(en)
|
2011-11-08 |
2013-05-09 |
Case Western Reserve University |
Targeted non-invasive imaging probes of egfr expressing cells
|
|
ES2729555T3
(es)
*
|
2011-11-30 |
2019-11-04 |
Univ Johns Hopkins |
Inhibidores homomultivalentes y heteromultivalentes de antígeno de membrana específico de próstata (PMSA) y usos de los mismos
|
|
US20140065070A1
(en)
*
|
2012-08-28 |
2014-03-06 |
Mcmaster University |
Methods of preparing triazole-containing radioiodinated compounds
|
|
EA201590783A1
(ru)
*
|
2012-11-15 |
2015-11-30 |
Эндосайт, Инк. |
Конъюгаты для доставки лекарственных средств и способы лечения заболеваний, вызванных клетками, экспрессирующими psma
|
|
PL2970345T3
(pl)
*
|
2013-03-15 |
2019-12-31 |
Cancer Targeted Technology Llc |
Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA
|
|
US10232058B2
(en)
|
2013-10-14 |
2019-03-19 |
The Johns Hopkins University |
Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy
|
|
EP3456700A1
(en)
|
2013-10-18 |
2019-03-20 |
Deutsches Krebsforschungszentrum |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
JP6292568B2
(ja)
*
|
2013-11-06 |
2018-03-14 |
国立大学法人京都大学 |
ウレア誘導体化合物、これを含有する放射性医薬
|
|
EP3533473A3
(en)
|
2013-11-14 |
2019-12-18 |
Endocyte, Inc. |
Compounds for positron emission tomography
|
|
US9713649B2
(en)
|
2014-01-24 |
2017-07-25 |
The Cleveland Clinic Foundation |
PSMA-targeting imaging agents
|
|
US10556916B2
(en)
*
|
2014-04-01 |
2020-02-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography
|
|
EP2993171A1
(en)
*
|
2014-09-04 |
2016-03-09 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for the production of 18F-labeled PSMA-specific PET-tracers
|
|
EP3183236B1
(en)
|
2014-08-24 |
2022-04-20 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften |
Method for the production of 18f-labeled active esters and their application exemplified by the preparation of a psma-specific pet-tracer
|
|
EP3209336B1
(en)
*
|
2014-10-20 |
2019-12-11 |
Deutsches Krebsforschungszentrum |
18f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
EP3011976A1
(en)
*
|
2014-10-20 |
2016-04-27 |
Deutsches Krebsforschungszentrum |
18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents
|
|
WO2016065142A2
(en)
|
2014-10-22 |
2016-04-28 |
The Johns Hopkins University |
New scaffolds and multifunctional intermediates for imaging psma and cancer therapy
|
|
US10188759B2
(en)
|
2015-01-07 |
2019-01-29 |
Endocyte, Inc. |
Conjugates for imaging
|
|
WO2016112382A2
(en)
*
|
2015-01-09 |
2016-07-14 |
The Johns Hopkins University |
Intranasal administration of glutamate carboxypeptidase (gcp-ii) inhibitors
|
|
US10869940B2
(en)
|
2015-06-12 |
2020-12-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Targeted photoacoustic compounds, formulations, and uses thereof
|
|
EP3337520A1
(en)
*
|
2015-08-20 |
2018-06-27 |
Universität zu Köln |
Pain tracking by pet-imaging (pain-trap)
|
|
KR102233726B1
(ko)
|
2015-09-30 |
2021-03-31 |
도이체스 크렙스포르슝스첸트룸 |
전립선 특이적 막 항원（psma)의 18f-태그된 저해제 및 전립선암에 대한 조영제로서 이의 용도
|
|
US20200231614A1
(en)
*
|
2015-10-22 |
2020-07-23 |
The Johns Hopkins University |
Psma targeted radiohalogenated ureas for cancer radiotherapy
|
|
KR101639599B1
(ko)
|
2015-11-09 |
2016-07-14 |
서울대학교산학협력단 |
펩타이드 싸이오우레아 유도체, 이를 포함하는 방사성 동위원소 표지 화합물 및 이를 유효 성분으로 함유하는 전립선암 치료 또는 진단용 약학적 조성물
|
|
EP3400229B1
(en)
|
2016-01-10 |
2024-03-06 |
Provincial Health Services Authority |
18/19f-labelled compounds which target the prostate specific membrane antigen
|
|
DK3481804T3
(da)
*
|
2016-06-10 |
2025-01-13 |
Univ Johns Hopkins |
Forbedret syntese af radioaktivt mærket hæmmer af prostataspecifikt membranantigen (PSMA) [18F]DCFPyL
|
|
CN109843339B
(zh)
*
|
2016-06-23 |
2023-07-07 |
康奈尔大学 |
影响肿瘤杀伤的双重靶向构建体
|
|
US10806806B2
(en)
|
2016-06-23 |
2020-10-20 |
Cornell University |
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
|
|
AU2017348111B2
(en)
|
2016-10-27 |
2023-04-06 |
Progenics Pharmaceuticals, Inc. |
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
|
|
JP6999960B2
(ja)
*
|
2016-11-17 |
2022-01-19 |
思路迪（北京）医薬科技有限公司 |
抗がん作用を有する化合物およびその製造方法ならびにその使用
|
|
DE102016122273B4
(de)
*
|
2016-11-18 |
2018-06-21 |
Abx Advanced Biochemical Compounds Gmbh |
Präkursoren für die Radiofluorierung
|
|
EP3609541A4
(en)
|
2017-04-05 |
2021-04-07 |
Cornell University |
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
|
|
MX2019012017A
(es)
|
2017-04-07 |
2020-02-12 |
Juno Therapeutics Inc |
Celulas modificadas que expresan antigeno de membrana especifico de prostata (psma) o una forma modificada del mismo y metodos relacionados.
|
|
WO2018204477A1
(en)
|
2017-05-02 |
2018-11-08 |
Cornell University |
Methods and reagents for tumor targeting with greater efficacy and less toxicity
|
|
WO2018236115A1
(ko)
|
2017-06-19 |
2018-12-27 |
(주)퓨쳐켐 |
전립선암 진단을 위한 18f-표지된 화합물 및 그의 용도
|
|
DK3643707T3
(da)
|
2017-06-19 |
2022-05-09 |
Futurechem Co Ltd |
18f-mærket forbindelse til diagnosticering af prostatkræft, og anvendelse deraf
|
|
EA202090776A1
(ru)
|
2017-10-23 |
2020-07-27 |
Дзе Джонс Хопкинс Юниверсити |
Визуализирующие и радиотерапевтические агенты, нацеленные на фибробласт-активирующий белок-альфа (fapalpha)
|
|
BR112020011727A2
(pt)
*
|
2017-12-11 |
2020-11-17 |
Technische Universität München |
ligantes de psma para imageamento e endorradioterapia
|
|
US10973486B2
(en)
|
2018-01-08 |
2021-04-13 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
|
|
US12602772B2
(en)
|
2018-01-08 |
2026-04-14 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
|
|
ES3026214T3
(en)
|
2018-01-08 |
2025-06-10 |
Progenics Pharm Inc |
System and method for rapid neural network-based image segmentation
|
|
US11813340B2
(en)
|
2018-02-06 |
2023-11-14 |
The Johns Hopkins University |
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy
|
|
WO2019183633A1
(en)
|
2018-03-23 |
2019-09-26 |
Case Western Reserve Univeristy |
Psma targeted conjugate compounds and uses thereof
|
|
CN112368024A
(zh)
|
2018-04-17 |
2021-02-12 |
恩多塞特公司 |
治疗癌症的方法
|
|
CN109160899B
(zh)
*
|
2018-05-16 |
2021-06-04 |
上海如絮生物科技有限公司 |
一种亲水性吡啶类化合物、中间体、其制备方法及应用
|
|
CN109160896B
(zh)
*
|
2018-05-16 |
2021-06-25 |
上海如絮生物科技有限公司 |
一种亲水性吡啶类化合物中间体及其制备方法
|
|
CN109160898B
(zh)
*
|
2018-05-16 |
2021-06-04 |
上海如絮生物科技有限公司 |
一种亲水性吡啶类化合物中间体及其制备方法
|
|
US20210338846A1
(en)
*
|
2018-07-30 |
2021-11-04 |
The Johns Hopkins University |
Competitive prostate-specific membrane antigen (psma) binding agents for reduction of non-target organ uptake of radiolabeled psma inhibitors for psma positive tumor imaging and radiopharmaceutical therapy
|
|
WO2020077259A1
(en)
|
2018-10-11 |
2020-04-16 |
Progenics Pharmaceuticals, Inc |
Combination therapy for treating metastatic prostate cancer
|
|
RU2697519C1
(ru)
*
|
2018-10-15 |
2019-08-15 |
Общество с ограниченной ответственностью "Изварино Фарма" |
Средство пептидной природы, включающее псма-связывающий лиганд на основе производного мочевины, способ его получения и применение для получения конъюгата с лекарственным и диагностическим агентом
|
|
WO2020139012A1
(ko)
|
2018-12-27 |
2020-07-02 |
(주)퓨쳐켐 |
카르복시산이 도입된 psma-표적 화합물 및 그의 용도
|
|
EP4597424A3
(en)
|
2019-01-07 |
2025-10-29 |
Exini Diagnostics AB |
Systems and methods for platform agnostic whole body image segmentation
|
|
PL239934B1
(pl)
|
2019-04-12 |
2022-01-31 |
Narodowe Centrum Badan Jadrowych Osrodek Radioizotopow Polatom |
Pochodne inhibitorów PSMA do znakowania ⁹⁹ᵐTc poprzez HYNIC, zestaw radiofarmaceutyczny, preparat radiofarmaceutyczny oraz ich zastosowanie w diagnostyce raka prostaty
|
|
AU2020257786B2
(en)
|
2019-04-17 |
2025-10-23 |
Provincial Health Services Authority |
Novel radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen-expressing cancer
|
|
JP7539921B2
(ja)
|
2019-04-24 |
2024-08-26 |
プロジェニクス ファーマシューティカルズ， インコーポレイテッド |
核医学画像における強度ウィンドウ処理の双方向調節のためのシステムおよび方法
|
|
BR112021021011A2
(pt)
|
2019-04-24 |
2021-12-14 |
Exini Diagnostics Ab |
Sistemas e métodos para análise automatizada e interativa de imagens de varredura óssea para detecção de metástases
|
|
CN114096264B
(zh)
|
2019-05-20 |
2025-03-14 |
因多塞特股份有限公司 |
制备psma缀合物的方法
|
|
BR112021025810A2
(pt)
|
2019-06-21 |
2022-05-10 |
Provincial Health Services Authority |
Compostos radiomarcados direcionando o antígeno de membrana específico da próstata
|
|
RU2713151C1
(ru)
*
|
2019-07-02 |
2020-02-04 |
Общество с ограниченной ответственностью "Изварино Фарма" |
Конъюгат флуоресцентного красителя с веществом пептидной природы, включающим псма-связывающий лиганд на основе производного мочевины для визуализации клеток, экспрессирующих псма, способ его получения и применения
|
|
AU2020336190A1
(en)
*
|
2019-08-30 |
2022-03-24 |
Memorial Sloan Kettering Cancer Center |
Novel theranostic agents for PSMA positive cancers
|
|
US12417533B2
(en)
|
2019-09-27 |
2025-09-16 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for artificial intelligence-based image analysis for cancer assessment
|
|
US11564621B2
(en)
|
2019-09-27 |
2023-01-31 |
Progenies Pharmacenticals, Inc. |
Systems and methods for artificial intelligence-based image analysis for cancer assessment
|
|
US11900597B2
(en)
|
2019-09-27 |
2024-02-13 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for artificial intelligence-based image analysis for cancer assessment
|
|
US11544407B1
(en)
|
2019-09-27 |
2023-01-03 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for secure cloud-based medical image upload and processing
|
|
KR102269315B1
(ko)
|
2019-10-24 |
2021-06-24 |
서울대학교산학협력단 |
전립선 암의 영상 또는 치료를 위한 동위원소 표지 화합물
|
|
US11321844B2
(en)
|
2020-04-23 |
2022-05-03 |
Exini Diagnostics Ab |
Systems and methods for deep-learning-based segmentation of composite images
|
|
US11386988B2
(en)
|
2020-04-23 |
2022-07-12 |
Exini Diagnostics Ab |
Systems and methods for deep-learning-based segmentation of composite images
|
|
CN111548305B
(zh)
*
|
2020-05-12 |
2021-08-31 |
北京师范大学 |
一种可用于靶向psma的喹啉类化合物及其制备方法
|
|
US11721428B2
(en)
|
2020-07-06 |
2023-08-08 |
Exini Diagnostics Ab |
Systems and methods for artificial intelligence-based image analysis for detection and characterization of lesions
|
|
CA3163190A1
(en)
|
2020-07-06 |
2022-01-13 |
Exini Diagnostics Ab |
Systems and methods for artificial intelligence-based image analysis for detection and characterization of lesions
|
|
EP4244216A1
(en)
|
2020-11-12 |
2023-09-20 |
ABX Advanced Biochemical Compounds GmbH |
Ligands of prostate specific membrane antigen (psma) containing heteroaromatic linker building blocks
|
|
CN114685599A
(zh)
*
|
2020-12-30 |
2022-07-01 |
南京江原安迪科正电子研究发展有限公司 |
一种psma靶向抑制剂及放射性核素标记的psma靶向抑制剂、制备方法和用途
|
|
KR20240072996A
(ko)
|
2021-07-30 |
2024-05-24 |
오사카 유니버시티 |
방사성 표지된 화합물 및 이의 용도
|
|
CA3231578A1
(en)
|
2021-10-08 |
2023-04-13 |
Exini Diagnostics Ab |
Systems and methods for automated identification and classification of lesions in local lymph and distant metastases
|
|
US20250332265A1
(en)
|
2021-11-09 |
2025-10-30 |
Case Western Reserve University |
Psma targeted conjugate compounds and uses thereof
|
|
CA3256961A1
(en)
|
2022-06-08 |
2023-12-14 |
Progenics Pharmaceuticals, Inc. |
SYSTEMS AND METHODS FOR ASSESSING THE BURDEN AND PROGRESSION OF A DISEASE
|
|
KR20250130683A
(ko)
|
2023-01-10 |
2025-09-02 |
썬 파마 어드밴스트 리서치 컴패니 리미티드 |
리간드-약물 접합체
|
|
US20240285248A1
(en)
|
2023-02-13 |
2024-08-29 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for predicting biochemical progression free survival in prostate cancer patients
|
|
CN116217505B
(zh)
*
|
2023-03-17 |
2024-10-01 |
南京医科大学 |
用于诊断或治疗表达前列腺特异性膜抗原癌症的新型标记靶向剂
|
|
US20240354940A1
(en)
|
2023-04-07 |
2024-10-24 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for facilitating lesion inspection and analysis
|
|
WO2025072177A1
(en)
|
2023-09-25 |
2025-04-03 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for automated cancer staging and risk prediction
|
|
WO2025090594A1
(en)
*
|
2023-10-25 |
2025-05-01 |
The Johns Hopkins University |
Deep transfer learning for fully automated tumor quantification and prognosis of cancer on pet/ct
|
|
DE102023133281B8
(de)
*
|
2023-11-28 |
2025-07-24 |
Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien Gmbh |
Radiotracer und Präkursoren für diese Radiotracer sowie Verwendung dieser Radiotracer als Diagnostika und Therapeutika
|
|
CN117670883B
(zh)
*
|
2024-01-31 |
2024-05-07 |
中国医学科学院北京协和医院 |
一种鉴别高低级别膀胱癌的方法、设备和系统
|